Clinical trial for Gestational Diabetes
Official title Intensive Glycemic Targets in Overweight and Obese Women With Gestational Diabetes
ClinicalTrials.gov ID: NCT05124808
What this study is testing
- What it's testing
- This study is testing whether aiming for tighter blood‑sugar levels improves outcomes for pregnant women who are overweight or obese and have gestational diabetes.
- Who it's for
- You may be able to join if you are pregnant, have gestational diabetes, and are overweight or obese.
- What's involved
- You will be assigned to either standard or tighter blood‑sugar targets and will have regular check‑ups to monitor your levels.
- Time commitment
- The study lasts until your baby is born, with several visits during pregnancy to track your progress.
Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 45, women only
You may be able to join if
- Pregnant women between the ages of 18-45
- Singleton gestation
- Gestational age between 12 0/7-32 6/7 weeks' gestation with gestational diabetes diagnosed during this time frame using either a 50g 1-hr GCT ≥200...
- Overweight or obese BMI at the first prenatal visit (BMI ≥25 kg/m2 or ≥23 kg/m2 in Asian Americans)
You likely can't join if
- Inability or unwillingness to provide informed consent
- Inability to communicate with members of the study team, despite the presence of an interpreter
- Planned delivery at a non-study affiliated hospital
- Known renal disease with a baseline creatinine \>1.5 mg/dL
- Significant fetal anomalies diagnosed prior to study enrollment (these will include anomalies such as gastroschisis, spina bifida, complex congenital...
- Oral or IV/IM steroid use within 7 days of study enrollment
The study team makes the final eligibility decision.
Where it is enrolling
- Birmingham, Alabama, United States
- Indianapolis, Indiana, United States
- Norman, Oklahoma, United States
- Pittsburgh, Pennsylvania, United States
- Providence, Rhode Island, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years to 45 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Birmingham, Alabama, United States; Indianapolis, Indiana, United States; Norman, Oklahoma, United States; Pittsburgh, Pennsylvania, United States; Providence, Rhode Island, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.